TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells

European Journal of Immunology

Volumn 44, Issue 6, 2014, Pages 1814-1822

  Bellora, Francesca ^a   Castriconi, Roberta ^a   Dondero, Alessandra ^a   Pessino, Anna ^b   Nencioni, Alessio ^a,b   Liggieri, Giovanni ^a   Moretta, Lorenzo ^c   Mantovani, Alberto ^d,e   Moretta, Alessandro ^a   Bottino, Cristina ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Human; Natural killer cells; Ovarian cancer; Tumor associated macrophages

Indexed keywords

2B4 RECEPTOR; CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR; DNAM 1 RECEPTOR; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; NTB A RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASCITES; CANCER PATIENT; CELL ACTIVATION; CELL ACTIVITY; CELL INTERACTION; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; NATURAL KILLER CELL; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; VERY ELDERLY;

HUMAN; NATURAL KILLER CELLS; OVARIAN CANCER; TUMOR-ASSOCIATED MACROPHAGES;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CYTOKINES; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MACROPHAGES; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TOLL-LIKE RECEPTORS;

EID: 84901832190     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344130     Document Type: Article

References (31)

1. Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A. and Locati, M., Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 2013. 229: 176-185.
2. Biswas, S. K. and Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010. 11: 889-896.
3. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F., Cancer-related inflammation. Nature 2008. 454: 436-444.
4. Hanahan, D. and Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011. 144: 646-674.
5. Ruffell, B., Affara, N. I. and Coussens, L. M., Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012. 33: 119-126.
6. Allavena, P. and Mantovani, A., Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin. Exp. Immunol. 2012. 167: 195-205.
7. Hagemann, T., Wilson, J., Burke, F., Kulbe, H., Li, N. F., Pluddemann, A., Charles, K. et al., Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 2006. 176: 5023-5032.
8. Komohara, Y., Ohnishi, K., Kuratsu, J. and Takeya, M., Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008. 216: 15-24.
9. Laoui, D., Movahedi, K., Van Overmeire, E., Van den Bossche, J., Schouppe, E., Mommer, C., Nikolaou, A. et al., Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int. J. Dev. Biol. 2011. 55: 861-867.
10. Moretta, L., Locatelli, F., Pende, D., Sivori, S., Falco, M., Bottino, C., Mingari, M. C. et al., Human NK receptors: from the molecules to the therapy of high risk leukemias. FEBS Lett. 2011. 585: 1563-1567.
11. Stojanovic, A. and Cerwenka, A., Natural killer cells and solid tumors. J. Innate. Immun. 2011. 3: 355-364.
12. Castriconi, R., Daga, A., Dondero, A., Zona, G., Poliani, P. L., Melotti, A., Griffero, F. et al., NK cells recognize and kill human glioblastoma cells with stem cell-like properties. J. Immunol. 2009. 182: 3530-3539.
13. Pietra, G., Manzini, C., Vitale, M., Balsamo, M., Ognio, E., Boitano, M., Queirolo, P. et al., Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. Int. Immunol. 2009. 21: 793-801.
14. Bellora, F., Castriconi, R., Dondero, A., Reggiardo, G., Moretta, L., Mantovani, A., Moretta, A. et al., The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc. Natl. Acad. Sci. USA 2010. 107: 21659-21664.
15. Parham, P. and Moffett, A., Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 2013. 13: 133-144.
16. Bottino, C., Castriconi, R., Moretta, L. and Moretta, A., Cellular ligands of activating NK receptors. Trends Immunol. 2005. 26: 221-226.
17. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011. 331: 44-49.
18. Bellora, F., Castriconi, R., Doni, A., Cantoni, C., Moretta, L., Mantovani, A., Moretta, A. et al., M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages. Eur. J. Immunol. 2012. 42: 1618-1626.
19. Martinez, F. O., Gordon, S., Locati, M. and Mantovani, A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006. 177: 7303-7311.
20. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. and Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002. 23: 549-555.
21. Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., Ratto, G. et al., CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007. 178: 4947-4955.
22. Garrido, F., Ruiz-Cabello, F., Cabrera, T., Perez-Villar, J. J., Lopez-Botet, M., Duggan-Keen, M. and Stern, P. L., Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today 1997. 18: 89-95.
23. Worthington, J. J., Klementowicz, J. E. and Travis, M. A., TGFbeta: a sleeping giant awoken by integrins. Trends Biochem. Sci. 2011. 36: 47-54.
24. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004. 25: 677-686.
25. Yu, J., Wei, M., Becknell, B., Trotta, R., Liu, S., Boyd, Z., Jaung, M. S. et al., Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006. 24: 575-590.
26. Allavena, P., Peccatori, F., Maggioni, D., Erroi, A., Sironi, M., Colombo, N., Lissoni, A. et al., Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. Cancer Res. 1990. 50: 7318-7323.
27. Harlin, H., Hanson, M., Johansson, C. C., Sakurai, D., Poschke, I., Norell, H., Malmberg, K. J. et al., The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J. Immunol. 2007. 179: 4513-4519.
28. Dowell, A. C., Oldham, K. A., Bhatt, R. I., Lee, S. P. and Searle, P. F., Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12. Cancer Immunol. Immunother. 2012. 61: 615-628.
29. Castriconi, R., Dondero, A., Bellora, F., Moretta, L., Castellano, A., Locatelli, F., Corrias, M. V. et al., Neuroblastoma-derived TGF-beta1 modulates the chemokine receptor repertoire of human resting NK cells. J. Immunol. 2013. 190: 5321-5328.
30. Gottschalk, N., Lang, S., Kimmig, R., Singh, M. and Brandau, S., Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines. BMC Cancer 2012. 12: 451.
31. Dunn-Siegrist, I., Tissieres, P., Drifte, G., Bauer, J., Moutel, S. and Pugin, J., Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules. J. Biol. Chem. 2012. 287: 16121-16131.